Inovio Pharmaceuticals Inc (NASDAQ:INO)

4.90
Delayed Data
As of May 25
 +0.06 / +1.24%
Today’s Change
3.76
Today|||52-Week Range
8.73
+18.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues10.5M40.6M35.4M42.2M
 
 
 
 
 
Depreciation And Amortization1.6M1.9M3.1M3.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses48.4M73.9M109.5M123.4M
 
 
 
 
 
Research And Development34.1M57.8M88.7M98.6M
 
 
 
 
 
Total Operating Expenses50.0M75.9M112.6M126.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.5M-35.3M-77.2M-84.6M
 
 
 
 
 
Extraordinary Credit3.0M2.8M1.2M806.8K
 
 
 
 
 
Extraordinary Charge---274.0K0.000.00
 
 
Other Expenses331.5K1.6M2.3M-4.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.1M-31.2M-73.7M-88.2M
 
 
 
 
 
Income Taxes0.00-2.1M0.000.00
 
 
Minority Interest-18.4K-84.8K0.000.00
 
 
 
Net Income-36.1M-29.2M-73.7M-88.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS59.1M68.2M73.2M81.8M
 
 
 
 
 
Shares To Calculate EPS Diluted59.4M68.4M73.2M81.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.64-$0.44-$1.01-$1.09
 
 
 
 
 
EPS Diluted-$0.64-$0.44-$1.01-$1.09